Rising Neurovascular Procedures Fuel Expansion in the U.S. Liquid Embolic Agent Market
The U.S. liquid embolic agent market, valued at USD 66.28 million in 2024, is forecast to expand at a CAGR of 9.0% during 2025–2034, with growth accelerating through segment-wise performance that highlights the importance of product differentiation and application-specific growth. As hospitals and interventional radiology centers demand precision-targeted solutions, the market is evolving...
0 Comments 0 Shares 383 Views 0 Reviews